{"SPADE_N_14424": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_N_14424", "Peptide Name": "VM-3K (VM P3K analog, Leu-rich, synthetic AMPs, XXA, UCLL1c; BBMm)", "Source": "amino acid substitution, insects, animal-derived, natural derivative", "Family": "Not found", "Gene": "Not found", "Sequence": "FLKIIGKLLSGLL", "Sequence Length": 13, "UniProt Entry": "Ref", "Protein Existence": "Not found", "Biological Activity": ["Anti-Gram+", "Anti-Gram-", "Antifungal", "Antifungal", "Anti-MRSA", "Hemolytic", "Antibiofilm"], "Target Organism": "Not found", "Hemolytic Activity": "Not found", "Cytotoxicity": "Not found", "Binding Target": "Not found", "Linear/Cyclic": "Not found", "N-terminal Modification": "Not found", "C-terminal Modification": "Not found", "Stereochemistry": "Not found", "Structure Description": "Not found", "Formula": "Not found", "Mass": 1414.82, "PI": 10.0, "Hydrophobicity": 1.65, "Half Life": "Not found", "Function": "Not found", "Literature": [{"Author": "Zhang J, Sun R, Chen Z, Zhou C, Ma C, Zhou M, Chen X, Chen T, Shaw C, Wang L.2022", "Reference": "Biology (Basel). 2022 Aug 25;11(9):1263. doi: 10.3390/biology11091263.PubMed", "Title": "Evaluation of the Antimicrobial Properties of a Natural Peptide from Vespa mandarinia Venom and Its Synthetic Analogues as a Possible Route to Defeat Drug-Resistant Microbes."}], "Frequent Amino Acids": "LGI", "Absent Amino Acids": "ACDEHMNOPQRTUVWY", "Basic Residues": 2, "Acidic Residues": 0, "Hydrophobic Residues": 8, "Polar Residues": 3, "Positive Residues": 2, "Negative Residues": 0, "Net Charge": 2, "Comments": "Sequence analysis: APD analysis reveals that this sequence is similar (92.31%) toVCP-VT1 or VML: 38%, I=G=K: 15%.Activity: Active against Gram+ S. aureus NCTC 6538 or MRSA ATCC 12493 (MIC 1 uM), E. faecalis NCTC 12697 (MIC 2 uM), Gram- E. coli ATCC 8739 (MIC 8 uM), K. pneumoniae ATCC 43816 (MIC 32 uM), P. aeruginosa ATCC 9027 (MIC 16 uM), and yeast C. albicans ATCC 10231 (MIC 32 uM). Also inhibited biofilms:bacteria:S. aureus (MBIC 2 uM; MBEC 32 uM); biofilms:bacteria:E. faecalis (MBIC 4 uM).MOA:bacteria:S. aureus: it permeabilized bacterial membranes (2xMIC, 50%).Structure:  random coil in 10 mM NH4Ac and helical in 50% TFE/NH4Ac.In vitro toxicity: horse RBC: HC50 11.2 uM, hemolytic.Animal model:wax moth: survival study: it protected the worms from death in a dose-dependent manner.Resistance development:no:bacteria:S. aureus: no resistance development after 16 cycles of passages.", "Similar Sequences": [{"SPADE_ID": "SPADE_UN_25816", "Similarity": 1.0, "Sequence": "FLKIIGKLLSGLL"}, {"SPADE_ID": "SPADE_UN_22571", "Similarity": 1.0, "Sequence": "GLLKIKTLL"}, {"SPADE_ID": "SPADE_UN_22580", "Similarity": 1.0, "Sequence": "GLLKITLL"}]}}}